Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant.
Nat Commun. 2016 May 13;7:11579. doi: 10.1038/ncomms11579.
Nat Commun. 2016.
PMID: 27174596
Free PMC article.
Clinical Trial.